Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_assertion type Assertion NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_head.
- NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_assertion wasGeneratedBy ECO_0000203 NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_provenance.
- NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_assertion wasDerivedFrom befree-20150227 NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_provenance.
- NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_assertion SIO_000772 11979307 NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_provenance.
- NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_assertion evidence source_evidence_literature NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_provenance.
- NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_assertion description "[Seventy-two patients with non-Hodgkin's lymphoma were evaluated for the presence of molecular markers (IgH, bcl-1, bcl-2 rearrangement) on bone marrow, at diagnosis and after PBSCT, and on harvests in order to find a possible predictive role of minimal residual disease on treatment outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_provenance.